 |
|
|
| |
SAFETY AND ANTIVIRAL ACTIVITY OF SCH 900518 ADMINISTERED AS MONOTHERAPY AND IN COMBINATION WITH PEGINTERFERON ALFA-2B TO NAIVE AND TREATMENT-EXPERIENCED HCV-1 INFECTED PATIENTS
|
| |
| |
EASL April 23-26 2009 Copenhagen Denmark
Reported by Jules Levin
H. W. Reesink, J. F. Bergmann, J. de Bruijne,
C. J. Weegink, J. van Lier, A. van Vliet, A. Keung, J. Li,
E. O'Mara, M. A. Treitel, E. A. Hughes,
H. L. A. Janssen, R. J. de Knegt
|
| |
|
|
|
|
|
